Evidence map›Paper›PMID 18639492›Full record

ArticleTuberculosis (Edinburgh, Scotland)2008

Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection.

Jennifer L Taylor, Helle Bielefeldt-Ohmann, Ambra Pozzi, Angelo A Izzo

Abstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jennifer L TaylorDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA. Jennifer.L.Taylor@Colostate.edu
Helle Bielefeldt-Ohmann
Ambra Pozzi
Angelo A Izzo
Colorado State University · USVanderbilt University · US

Funding

Metalloproteinase Functon in Tuberculosis GranulomasR21AI052040 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI IZZO, ANGELO A. · 2004 to 2004
$326k
NIAID NIH HHS AI52040NIAID NIH HHS R21 AI052040
6 · The paper itself

Abstract

The hallmark of Mycobacterium tuberculosis infection is the granuloma, a highly dynamic immune structure that contains the bacilli during chronic infection. Here, we examined if alpha1beta1 integrin is required in the development and maintenance of the granulomatous structure during pulmonary infection using the alpha1 integrin knockout (alpha1-null) mouse. The alpha1beta1 integrin is expressed on activated macrophages and T cells, and interacts with collagen molecules in the extracellular matrix (ECM), and thus may play a role in the granulomatous process. Following pulmonary infection with virulent M. tuberculosis, lungs of alpha1-null infected mice had striking differences in granuloma structure, as well as distinct and markedly thickened alveolar septae. By day 180, there were regions of cell death within granulomatous lesions, characterized by cellular debris in these mice. To determine if this molecule was necessary for T cell trafficking within the lungs, the expression of CD4, CD44 and CD62L was monitored. The number of activated and IFN-gamma-producing CD4+ T cells increased in the lungs of alpha1-null mice during the chronic phase of infection, although they had decreased concentrations of TNF-alpha and MMP-9. These results suggest that while alpha1beta1 integrin is not required for trafficking or maintenance of T cells in M. tuberculosis infected lungs, it does play a role in granuloma structure and integrity during the chronic phase of infection.

Indexed as

AnimalsDown-RegulationFemaleFlow CytometryGranulomaHumansImmunity, CellularIntegrin alpha4beta1LungMacrophagesMiceMice, Inbred BALB CMycobacterium tuberculosisT-LymphocytesTuberculosis, PulmonaryIntegrin alpha4beta1

Identifiers

PMID18639492
PMCPMC2613756
OpenAlexW2167939845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.